Factors Affecting Cytokine Change After Esophagectomy for Esophageal Cancer

Annals of Surgical Oncology

Volumn 22, Issue 9, 2015, Pages 3130-3135

  Okamura, Akihiko ^a   Takeuchi, Hiroya ^a   Matsuda, Satoru ^a   Ogura, Masaharu ^a   Miyasho, Taku ^b   Nakamura, Rieko ^a   Takahashi, Tsunehiro ^a   Wada, Norihito ^a   Kawakubo, Hirofumi ^a   Saikawa, Yoshiro ^a   Kitagawa, Yuko ^a  

^a KEIO UNIVERSITY   (Japan)

^b RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; CYTOKINE; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ADULT; AGE; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CONCENTRATION (PARAMETERS); DISEASE SEVERITY; ENDOSCOPIC SURGERY; ENTERIC FEEDING; ENZYME LINKED IMMUNOSPOT ASSAY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPERATION DURATION; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; SURGICAL APPROACH; SURGICAL INFECTION; SURGICAL PATIENT; THORACOSCOPY; BLOOD; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

CARCINOMA, SQUAMOUS CELL; CYTOKINES; ENTERAL NUTRITION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; NEOPLASM STAGING; OPERATIVE TIME; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS;

EID: 84938992919     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-4348-4     Document Type: Article

References (40)

1. Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379:1887–92.
2. Sato N, Endo S, Kimura Y, et al. Influence of a human protease inhibitor on surgical stress induced immunosuppression. Dig Surg. 2002;19:300–5.
3. Khansari DN, Murgo AJ, Faith RE. Effects of stress on the immune system. Immunol Today. 1990;11:170–5.
4. Ogawa K, Hirai M, Katsube T, et al. Suppression of cellular immunity by surgical stress. Surgery. 2000;127:329–36.
5. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol. 2003;10:972–92.
6. Hogan BV, Peter MB, Shenoy HG, Horgan K, Hughes TA. Surgery induced immunosuppression. Surgeon. 2011;9:38–43.
7. Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb. 1992;37:7–11.
8. Ono S, Aosasa S, Mochizuki H. Effects of a protease inhibitor on reduction of surgical stress in esophagectomy. Am J Surg. 1999;177:78–82.
9. Sato N, Koeda K, Ikeda K, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236:184–90.
10. Suda K, Kitagawa Y, Ozawa S, et al. Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus. 2007;20:478–86.
11. Dapri G, Himpens J, Cadiere GB. Minimally invasive esophagectomy for cancer: laparoscopic transhiatal procedure or thoracoscopy in prone position followed by laparoscopy? Surg Endosc. 2008;22:1060–9.
12. Biere SS, Cuesta MA, van der Peet DL. Minimally invasive versus open esophagectomy for cancer: a systematic review and meta-analysis. Minerva Chir. 2009;64:121–33.
13. Safranek PM, Cubitt J, Booth MI, Dehn TC. Review of open and minimal access approaches to oesophagectomy for cancer. Br J Surg. 2010;97:1845–53.
14. Briez N, Piessen G, Torres F, Lebuffe G, Triboulet JP, Mariette C. Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications. Br J Surg. 2012;99:1547–53.
15. Frick VO, Justinger C, Rubie C, Graeber S, Schilling MK, Lindemann W. Thoracotomy procedures effect cytokine levels after thoracoabdominal esophagectomy. Oncol Rep. 2012;27:258–64.
16. Tsujimoto H, Takahata R, Nomura S, et al. Video-assisted thoracoscopic surgery for esophageal cancer attenuates postoperative systemic responses and pulmonary complications. Surgery. 2012;151:667–73.
17. Goldberg RF, Bowers SP, Parker M, Stauffer JA, Asbun HJ, Smith CD. Technical and perioperative outcomes of minimally invasive esophagectomy in the prone position. Surg Endosc. 2013;27:553–7.
18. Zhang L, Wang N, Zhou S, et al. Preventive effect of ulinastatin on postoperative complications, immunosuppression, and recurrence in esophagectomy patients. World J Surg Oncol. 2013;11:84.
19. Kaburagi T, Takeuchi H, Kawakubo H, Omori T, Ozawa S, Kitagawa Y. Clinical utility of a novel hybrid position combining the left lateral decubitus and prone positions during thoracoscopic esophagectomy. World J Surg. 2014;38:410–8.
20. Shyamsundar M, McAuley DF, Shields MO, et al. Effect of simvastatin on physiological and biological outcomes in patients undergoing esophagectomy: a randomized placebo-controlled trial. Ann Surg. 2014;259:26–31.
21. Takeuchi H, Kawakubo H, Kitagawa Y. Current status of minimally invasive esophagectomy for patients with esophageal cancer. Gen Thorac Cardiovasc Surg. 2013;61:513–21.
22. Kawakubo H, Takeuchi H, Kitagawa Y. Current status and future perspectives on minimally invasive esophagectomy. KoreanJ Thorac Cardiovasc Surg. 2013;46:241–8.
23. Watanabe M, Baba Y, Nagai Y, Baba H. Minimally invasive esophagectomy for esophageal cancer: an updated review. Surg Today. 2013;43:237–44.
24. Sobin LH, Gospodarowicz MK, Wittekind CW. TNM classification of malignant tumours. 7th ed. New York: Wiley-Blackwell; 2009.
25. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
26. Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med. 1992;20:724–6.
27. Lin E, Lowry SF. Inflammatory cytokines in major surgery: a functional perspective. Intensive Care Med. 1999;25:255–7.
28. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24:1125–8.
29. Duignan JP, Collins PB, Johnson AH, Bouchier-Hayes D. The association of impaired neutrophil chemotaxis with postoperative surgical sepsis. Br J Surg. 1986;73:238–40.
30. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg. 1993;80:205–9.
31. Takeuchi H, Saikawa Y, Oyama T, et al. Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J Surg. 2010;34:277–84.
32. Haga Y, Beppu T, Dox K, et al. Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Crit Care Med. 1997;25:1994–2000.
33. Morita M, Yoshida R, Ikeda K, et al. Acute lung injury following an esophagectomy for esophageal cancer, with special reference to the clinical factors and cytokine levels of peripheral blood and pleural drainage fluid. Dis Esophagus. 2008;21:30–6.
34. Tsujimoto H, Takahata R, Nomura S, et al. Predictive value of pleural and serum interleukin-6 levels for pneumonia and hypo-oxygenations after esophagectomy. J Surg Res. 2013;182:e61–7.
35. Couper G. Jejunostomy after oesophagectomy: a review of evidence and current practice. Proc Nutr Soc. 2011;70:316–20.
36. Fujita T, Daiko H, Nishimura M. Early enteral nutrition reduces the rate of life-threatening complications after thoracic esophagectomy in patients with esophageal cancer. Eur Surg Res. 2012;48:79–84.
37. Xiao-Bo Y, Qiang L, Xiong Q, et al. Efficacy of early postoperative enteral nutrition in supporting patients after esophagectomy. Minerva Chir. 2014;69:37–46.
38. Weijs TJ, Berkelmans GH, Nieuwenhuijzen GA, et al. Routes for early enteral nutrition after esophagectomy. A systematic review. Clin Nutr. 2014. doi:10.1016/j.clnu.2014.07.011.
39. Takagi K, Yamamori H, Toyoda Y, Nakajima N, Tashiro T. Modulating effects of the feeding route on stress response and endotoxin translocation in severely stressed patients receiving thoracic esophagectomy. Nutrition. 2000;16:355–60.
40. Kotani J, Usami M, Nomura H, et al. Enteral nutrition prevents bacterial translocation but does not improve survival during acute pancreatitis. Arch Surg. 1999;134:287–92.